
4th year med student at AIIMS Delhi // intern @UltrahumanHQ // building @usepapertrace // health and startups
hyd/delhi
Joined September 2025
- Tweets6.3K
- Following2.8K
- Followers3.5K
- Likes13.9K
Arnesh retweeted
For birthdays, big milestones, little celebrations and everything in between. There’s always someone who’s impossible to shop for, but impossible not to celebrate.
Introducing Ultrahuman Gift Cards. Give someone close to you the gift of good health.
Choose a card, add a personal note and let them pick their perfect Ultrahuman Ring.
Find out more here: bit.ly/4j2jNwo
Arnesh retweeted
introducing, curovana for clinics!
An agentic clinic operating system, built specifically for happier patients, doctors and clinic staff.
Arnesh retweeted
We’re making a personalized cancer vaccine for Yash, a 34 year-old pancreatic cancer patient, in the open with his consent.
We want external experts to review our design and make their own contributions before we manufacture it at the RNA Foundry.
RNAFoundry.com/yash
Arnesh retweeted
It's just a blood test.
No one will pay for a subscription.
Design is not a moat.
Ultrahuman is going to kill you.
You don't have healthcare experience.
You need to find a co-founder.
You're not from an IIT.
You have no experience.
The CAC will be too high.
Orange Labs is going to kill you.
India is a trust deficit market.
Too early for preventative health in India.
Claude is going to kill you.
It's too competitive.
There are no margins in blood testing.
OpenAI is going to kill you.
You're not solving a big enough problem statement.
People will use AI to build their own software.
Blood tests are a commodity.
You don't have a moat.
It's too expensive.
You can't raise funds.
You should build your own wearable instead.
Google is going to kill you.
Indians don't care about brand.
You're targeting only the 0.01% of India.
You can't scale it with only organic marketing.
Your CAC to LTV ratio will be very low.
You should pivot.
You should be an AI health coach.
You can't build both product and distribution at the same time.
It's too risky.
Consumers won't pay for a premium product.
You should target tier 2 and tier 3.
Cent is going to kill you.
You aren't fast enough.
You're not seeing the big picture.
You're just a kid.
You're just an engineer, you need doctors.
...
just keep going.
Happy Diwali everyone 🪔🩵
You have no experience.
You’ve never started a company.
You’ve never had a full time job.
Nike is going to kill you.
You’re a kid.
You don’t have technical skills.
You shouldn’t build hardware.
Apple is going to kill you.
You can’t build hardware.
You can’t measure heart rate non-invasively.
Athletes don’t care about recovery.
Under Armour is going to kill you.
It won’t be accurate.
You don’t listen.
You’re an ineffective leader.
You can’t recruit great talent.
You’re going to have to pay every athlete.
You can’t measure sleep non-invasively.
It’s too expensive to research.
Athletes are a small market.
The product costs too much to make.
The product costs too much to sell.
Your valuation is too high.
Consumers aren’t going to want it.
Hardware is too hard.
You should measure steps.
Fitbit is going to kill you.
You can’t build a marketing engine.
You can’t raise enough money.
You need a real CEO.
Google is going to kill you.
You can’t be a subscription.
You can’t build a brand.
You can’t do consumer in Boston.
Your valuation is too high.
You shouldn’t make accessories.
You shouldn’t make apparel.
Lululemon is going to kill you.
You can’t predict Covid.
Stay in your niche.
You are going to run out of money.
You can’t build a health platform.
Amazon is going to kill you.
You can’t measure blood pressure.
You can’t get medical approvals.
The market is too small.
You don’t understand AI.
The market is too competitive.
It won’t work internationally.
The supply chain is too complicated.
You can’t build an AI.
You can’t raise enough money.
It’s too competitive.
Healthcare isn’t going to want it.
…
Just keep going ✌️
Arnesh retweeted
I wish there was a way to mark replies as AI slop, would improve the X experience significantly.































